{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:08:57Z","timestamp":1788869337312,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.preghy.2026.101500","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:52:55Z","timestamp":1784217175000},"page":"101500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["FGF2 and PTX3 plasma levels as potential biomarkers for early-onset pre-eclampsia"],"prefix":"10.1016","volume":"45","author":[{"given":"Fl\u00e1via Santiago","family":"de Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza Oliveira","family":"Perucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia Nessralla","family":"Alpoim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luci Maria","family":"Sant'Ana Dusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Abalen Martins","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2026.101500_bb0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","article-title":"Pre-eclampsia: pathogenesis, novel diagnostics and therapies","volume":"15","author":"Phipps","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.preghy.2026.101500_bb0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of hypertension in pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2026.101500_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9378(95)91324-6","article-title":"Underlying disorders associated with severe early-onset preeclampsia","author":"Dekker","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2026.101500_bb0020","doi-asserted-by":"crossref","DOI":"10.1080\/10641955.2025.2470626","article-title":"Preeclampsia pathogenesis and prediction - where are we now: the focus on the role of galectins and miRNAs","volume":"44","author":"Karadzov Orlic","year":"2025","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.preghy.2026.101500_bb0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.placenta.2025.09.017","article-title":"NNMT expression in preeclampsia: analyses on placental tissues and cell lines","volume":"171","author":"Tossetta","year":"2025","journal-title":"Placenta"},{"key":"10.1016\/j.preghy.2026.101500_bb0030","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s13577-023-00901-x","article-title":"Downregulation of argininosuccinate synthase 1 (ASS1) is associated with hypoxia in placental development","volume":"36","author":"Fantone","year":"2023","journal-title":"Hum. Cell"},{"key":"10.1016\/j.preghy.2026.101500_bb0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cytogfr.2005.01.004","article-title":"Fibroblast growth factor\/fibroblast growth factor receptor system in angiogenesis","volume":"16","author":"Presta","year":"2005","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.preghy.2026.101500_bb0040","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/med.21288","article-title":"FGF receptors: cancer biology and therapeutics","volume":"34","author":"Katoh","year":"2014","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.preghy.2026.101500_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2018.02327","article-title":"Long pentraxin-3 modulates the angiogenic activity of fibroblast growth factor-2","volume":"9","author":"Presta","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.preghy.2026.101500_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.663044","article-title":"Fibroblast growth factor type 2 (FGF2) administration attenuated the clinical manifestations of preeclampsia in a murine model induced by L-NAME","volume":"12","author":"Martinez-Fierro","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.preghy.2026.101500_bb0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/08977199609003225","article-title":"Localisation of placenta growth factor (PIGF) in human term placenta","volume":"13","author":"Khaliq","year":"1996","journal-title":"Growth Factors"},{"key":"10.1016\/j.preghy.2026.101500_bb0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1081\/PRG-120016790","article-title":"Basic fibroblast growth factor and hypertensive disorders in pregnancy","volume":"21","author":"Hohlagschwandtner","year":"2002","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.preghy.2026.101500_bb0065","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/107155760100800104","article-title":"Maternal basic fibroblast growth factor serum levels are associated with pregnancy-induced hypertension","volume":"8","author":"Kurz","year":"2001","journal-title":"J. Soc. Gynecol. Investig."},{"key":"10.1016\/j.preghy.2026.101500_bb0070","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1152\/physrev.00016.2017","article-title":"PTX3, a humoral pattern recognition molecule, in innate immunity, tissue repair, and cancer","volume":"98","author":"Garlanda","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.preghy.2026.101500_bb0075","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.ajog.2005.11.018","article-title":"Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction","volume":"194","author":"Cetin","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2026.101500_bb0080","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1080\/00016340902971441","article-title":"First trimester PTX3 levels in women who subsequently develop preeclampsia and fetal growth restriction","volume":"88","author":"Cetin","year":"2009","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.preghy.2026.101500_bb0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.preghy.2018.03.005","article-title":"Estimation of asymmetric dimethylarginine (ADMA), placental growth factor (PLGF) and pentraxin 3 (PTX 3) in women with preeclampsia","volume":"14","author":"Garg","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2026.101500_bb0090","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0412.2011.01238.x","article-title":"Impaired endothelial function and elevated levels of pentraxin 3 in early-onset preeclampsia","volume":"91","author":"Hamad","year":"2012","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.preghy.2026.101500_bb0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1182\/blood-2003-10-3433","article-title":"Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis","volume":"104","author":"Rusnati","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.preghy.2026.101500_bb0100","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1158\/1535-7163.MCT-11-0286","article-title":"Long pentraxin-3 inhibits FGF8b-dependent angiogenesis and growth of steroid hormone-regulated tumors","volume":"10","author":"Leali","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.preghy.2026.101500_bb0105","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s10753-010-9252-x","article-title":"Pentraxin 3 values during normal pregnancy","volume":"34","author":"Larsson","year":"2011","journal-title":"Inflammation"},{"key":"10.1016\/j.preghy.2026.101500_bb0110","first-page":"157","article-title":"Changes in maternal plasma levels of VEGF, bFGF, TGF-\u03b21, ET-1 and sKL during uncomplicated pregnancy, hypertensive pregnancy and gestational diabetes","volume":"20","author":"Lygnos","year":"2006","journal-title":"In Vivo (Brooklyn)."},{"key":"10.1016\/j.preghy.2026.101500_bb0115","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/10408363.2018.1476455","article-title":"Influence of ethnicity on population reference values for biochemical markers","volume":"55","author":"Tahmasebi","year":"2018","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.preghy.2026.101500_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2015.05.004","article-title":"Is the imbalance between pro-angiogenic and anti-angiogenic factors associated with preeclampsia?","author":"Jardim","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.preghy.2026.101500_bb0125","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/j.1582-4934.2008.00415.x","article-title":"A pro-inflammatory signature mediates FGF2-induced angiogenesis","volume":"13","author":"Andr\u00e9s","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.preghy.2026.101500_bb0130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1006\/dbio.1993.1205","article-title":"Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2)","volume":"158","author":"Orr-Urtreger","year":"1993","journal-title":"Dev. Biol."},{"key":"10.1016\/j.preghy.2026.101500_bb0135","first-page":"4513","article-title":"Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy","volume":"13","author":"Yan","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.preghy.2026.101500_bb0140","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1242\/dev.127.3.483","article-title":"An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis","volume":"127","author":"De Moerlooze","year":"2000","journal-title":"Development"},{"key":"10.1016\/j.preghy.2026.101500_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpobgyn.2024.102480","article-title":"Preeclampsia epidemiology(ies) and pathophysiology(ies)","volume":"94","author":"Roberts","year":"2024","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.preghy.2026.101500_bb0150","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1262\/jrd.10-008K","article-title":"Hypoxia induces FGF2 production by vascular endothelial cells and alters MMP9 and TIMP1 expression in extravillous trophoblasts and their invasiveness in a cocultured model","volume":"57","author":"Luo","year":"2011","journal-title":"J. Reprod. Dev."},{"key":"10.1016\/j.preghy.2026.101500_bb0155","doi-asserted-by":"crossref","first-page":"32325","DOI":"10.1074\/jbc.M405208200","article-title":"FGF-2 induced by interleukin-1\u03b2 through the action of phosphatidylinositol 3-kinase mediates endothelial mesenchymal transformation in corneal endothelial cells","volume":"279","author":"Lee","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preghy.2026.101500_bb0160","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1074\/jbc.M703090200","article-title":"Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1","volume":"283","author":"Finetti","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preghy.2026.101500_bb0165","doi-asserted-by":"crossref","first-page":"220","DOI":"10.12891\/ceog2077.2016","article-title":"Correlation of the system of cytokines in moderate and severe preeclampsia","volume":"43","author":"Daneva","year":"2016","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2026.101500_bb0170","doi-asserted-by":"crossref","DOI":"10.1177\/1179545X17752325","article-title":"Preeclampsia: from inflammation to immunoregulation","volume":"11","author":"Cornelius","year":"2018","journal-title":"Clin. Med. Insights Blood Disord."},{"key":"10.1016\/j.preghy.2026.101500_bb0175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1684\/ecn.2009.0155","article-title":"Inflammatory cells and chemokines sustain FGF2-induced angiogenesis","volume":"20","author":"Presta","year":"2009","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.preghy.2026.101500_bb0180","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jhep.2016.02.029","article-title":"The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling","volume":"64","author":"Bottazzi","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.preghy.2026.101500_bb0185","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.placenta.2012.09.009","article-title":"PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR","volume":"33","author":"Cozzi","year":"2012","journal-title":"Placenta"},{"key":"10.1016\/j.preghy.2026.101500_bb0190","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1081\/PRG-120021060","article-title":"Subclassification of preeclampsia","volume":"22","author":"Von Dadelszen","year":"2003","journal-title":"Hypertens. Pregnancy"}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778926000887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778926000887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:21:02Z","timestamp":1788866462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778926000887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":38,"alternative-id":["S2210778926000887"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2026.101500","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FGF2 and PTX3 plasma levels as potential biomarkers for early-onset pre-eclampsia","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2026.101500","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in Pregnancy.","name":"copyright","label":"Copyright"}],"article-number":"101500"}}